Table 3 Follow-up characteristics of patients combined with moderate aortic regurgitation .

From: Clinical outcomes and management strategies for moderate aortic regurgitation in patients undergoing rheumatic mitral valve surgery

Characteristic

Total

(N = 321)

NT

(N = 118)

AVP

(N = 89)

AVR

(N = 114)

P value

Follow-up duration (month)

43.4

(19.5, 72.0)

43.8

(17.5, 67.5)

40.2

(14.0, 72.0)

46.5

(26.0, 83.2)

0.15

Follow-up mortality

12 (3.7)

2 (1.7)

2 (2.2)

8 (7.0)

0.07

Follow-up cardiac valve reoperation

7 (2.2)

2 (1.7)

2 (2.2)

3 (2.6)

0.89

    Mitral valve reoperation

6 (1.9)

2 (1.7)

2 (2.2)

2 (1.8)

0.95

    Aortic valve reoperation

3 (0.9)

0 (0)

1 (1.1)

2 (1.8)

0.37

Secondary outcomes

21 (6.5)

5 (4.2)

5 (5.6)

11 (9.6)

0.23

Valve-related complications

46 (14.9)

16 (14.2)

10 (11.2)

20 (18.7)

0.33

  1. Values are median (interquartile range) ; n (%). NT, non-surgical treatment; AVP, aortic valvuloplasty; AVR, aortic valve replacement; secondary endpoint events include all-cause mortality and cardiac reoperation both before discharge and during follow-up.
Back to article page